Malaria

7.

“Friends” Organisations Promote the Work of the Global Fund

25 Oct 2012

Since the establishment of the Global Fund in 2002, various organisations have been formed as “Friends of the Fund.” They promote the work of the Fund and mobilise financial and political support for it.

2.

Future of AMFm to Be Decided at Global Fund Board Meeting in November

9 Oct 2012
Outcome is uncertain
Independent evaluation describes the AMFm as a “game-changer” for the private sector

The future of the Affordable Medicines Facility–malaria (AMFm) will be decided at the Global Fund Board meeting on 14–15 November 2012. The outcome appears anything but certain. The AMFm was launched as a two-year pilot phase in April 2009 and began operations in July 2010. The AMFm is hosted by the Global Fund but its programme funding comes from other donors.

5.

Malaria Grant Renewals in Nigeria Include $50 million in “New” Money

9 Oct 2012

The Global Fund Board recently approved two Round 8 malaria grant renewals for Nigeria worth $225 million. This amount included $50 million in “new” money, which will be used to purchase bed nets.

7.

Global Fund Board Approves “Re-Launch” of Malaria Grant in Mozambique

9 Oct 2012
“New” grant focuses on systems strengthening and capacity building

In June 2012, the Global Fund Board approved the “re-launch” of a health systems strengthening (HSS) grant in Mozambique. After two years of inactivity, the grant was re-launched as a three-year re-programmed grant. It is believed to be the first time a grant has ever been re-launched.

6.

Aidspan Reviews an Academic Study on the Effect of Investment in Malaria Control on Child Mortality

20 Sep 2011

A new publication from Aidspan, by Dr David McCoy, reviews a published academic study on the impact of Global Fund grants for malaria prevention.

4.

Debt Swap Agreement Between Germany and Egypt Will Benefit Global Fund Programmes in Ethiopia

25 Jul 2011

The Global Fund has brokered debt swap agreement before, but not like the latest one between Germany and Egypt.

5.

Global Fund Reports Sharp Drop in ACT Prices in Two AMFm Countries

25 Jul 2011

According to data compiled by the Global Fund, since the introduction of the Affordable Medicines Facility-malaria (AMFm) programme, the average cost of a course of artemisinin combination therapy (ACT) in private pharmacies has dropped by about 90% in parts of Kenya and by about 40% to 90% in Ghana, the first two countries to participate in the programme.

6.

Global Fund and Manufacturers Reduce Prices of Malaria Drugs in Eight Countries

8 Oct 2010

Malaria patients in eight countries in sub-Saharan Africa and Asia will pay significantly less for ACTs (artemisinin-based combination therapies) purchased through the private health care system, as a result of agreements between the Global Fund and six manufacturers of malaria drugs.

5.

Global Fund Launches Its SOGI Strategy

20 Sep 2010

The Global Fund plans to monitor and publicise cases where funding proposals have been, or might be, rejected due to policy environments where human rights violations are impeding the implementation or impact of interventions against AIDS, TB and malaria. This is one of the highlights of the Global Fund's policy and implementation plan on Sexual Orientation and Gender Identity (SO

6.

Seeking Nominations for Communities Delegation on the Global Fund Board

21 May 2010

The Global Fund Board's delegation of Communities Living with HIV, TB and affected by malaria is looking for people willing to be part of the delegation for a three-year period, from 2011 through 2013.

Pages

Subscribe to Malaria